These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11751961)

  • 41. Th2 cells shape the differentiation of developing T cell responses during interactions with dendritic cells in vivo.
    Schipf A; Heilmann A; Boue L; Mossmann H; Brocker T; Röcken M
    Eur J Immunol; 2003 Jun; 33(6):1697-706. PubMed ID: 12778488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-2 and IL-7 differentially induce CD4-CD8- alpha beta TCR+NK1.1+ large granular lymphocytes and IL-4-producing cells from CD4-CD8- alpha beta TCR+NK1.1- cells: implications for the regulation of Th1- and Th2-type responses.
    Nishizawa K; Koyasu S
    Int Immunol; 1997 Aug; 9(8):1123-9. PubMed ID: 9263009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Constraints in antigen processing result in unresponsiveness to a T cell epitope of hen egg lysozyme in C57BL/6 mice.
    Kim BS; Jang YS
    Eur J Immunol; 1992 Mar; 22(3):775-82. PubMed ID: 1372259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
    Niedbala W; Wei X; Liew FY
    Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
    Wang X; Mosmann T
    J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for cooperation between TCR V region and junctional sequences in determining a dominant cytotoxic T lymphocyte response to herpes simplex virus glycoprotein B.
    Jones CM; Cose SC; Carbone FR
    Int Immunol; 1997 Sep; 9(9):1319-28. PubMed ID: 9310835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing the frequency of T-cell precursors specific for a cryptic epitope of hen-egg lysozyme converts it to an immunodominant epitope.
    Thatcher TH; O'Brien DP; Altuwaijri S; Barth RK
    Immunology; 2000 Feb; 99(2):235-42. PubMed ID: 10692042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
    J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of precursor Th cells in mesenteric lymph nodes after oral immunization with protein antigen and cholera toxin.
    Schaffeler MP; Brokenshire JS; Snider DP
    Int Immunol; 1997 Oct; 9(10):1555-62. PubMed ID: 9352361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.
    Tao X; Grant C; Constant S; Bottomly K
    J Immunol; 1997 May; 158(9):4237-44. PubMed ID: 9126985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell lines specific for a synthetic Heymann nephritis peptide derived from the receptor-associated protein.
    Wu H; Zhang GY; Knight JF
    Clin Exp Immunol; 2000 Jul; 121(1):157-64. PubMed ID: 10886254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
    Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR
    Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope.
    Pingel S; Launois P; Fowell DJ; Turck CW; Southwood S; Sette A; Glaichenhaus N; Louis JA; Locksley RM
    J Exp Med; 1999 Apr; 189(7):1111-20. PubMed ID: 10190902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of CTLA-4 in regulating Th2 differentiation.
    Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
    J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
    Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
    J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells.
    Ria F; Penna G; Adorini L
    Eur J Immunol; 1998 Jun; 28(6):2003-16. PubMed ID: 9645382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
    Rosloniec EF; Gay D; Freed JH
    J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of the IL-12 receptor beta2 subunit by soluble antigen and IL-12 in vivo.
    Galbiati F; Rogge L; Guéry JC; Smiroldo S; Adorini L
    Eur J Immunol; 1998 Jan; 28(1):209-20. PubMed ID: 9485201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.